 |  |
| Efective for clinical /subclinical mastitis treatment | Normalizes somatic cell count (SCC) |
 |  |
| Improves dairy cattle welfare | Higher profitability |
 |  |
| Higher milk quality and yields |
ACOUSTIC PULSE THERAPY (APT)
ACOUSTIC PULSE THERAPY (APT)
Armenta has developed APT, a patented system specifically designed for a clinical / subclinical mastitis treatment in dairy cattle.
Bovine mastitis, an inflammation of the mammary gland and the udder tissue, is the endemic pathology that causes the greatest production loses in the dairy cattle industry all over the world, representing a loss of more than U$ 2 billion annual revenue in the USA. Mastitis lowers production and quality of milk.
APT is based on the patented low intensity shock waves technology, that has been extensively documented in the last 35 years for the treatment on patients with inflammatory diseases, cardiac ischaemia and erectile dysfunction. This therapy generates new blood vessels, triggers the immune system, reduces inflammation and improves the function of the tissues with a long-term efect.
APT is based on the patented low intensity shock waves technology, that has been extensively documented in the last 35 years for the treatment on patients with inflammatory diseases, cardiac ischaemia and erectile dysfunction. This therapy generates new blood vessels, triggers the immune system, reduces inflammation and improves the function of the tissues with a long-term efect.
TREATMENT ADVANTAGES
 |
| Low intensity and deep penetration acoustic pulses |
 |
| Wide area of treatment |
 |
| Safe and easily tolerable |
 |
| Easy operation system |
 |
| Swift application |
TREATMENT ADVANTAGES
|
| Low intensity and deep penetration acoustic pulses |
|
| Wide area of treatment |
|
| Safe and easily tolerable |
|
| Easy operation system |
|
| Swift application |
BENEFITS
 |
|
|
|
|
